Clinical & Molecular Biomedicine (CMB) is committed to supporting open access publication and the broad dissemination of biomedical research.

Currently, no article processing charges are required for publication in Clinical & Molecular Biomedicine.

Authors are not required to pay an article processing charge for accepted manuscripts at this time.

All articles published in Clinical & Molecular Biomedicine are made available through a fully open-access model, ensuring immediate and unrestricted access to readers worldwide.

This open access model supports wider dissemination of published research and allows readers to access articles without subscription barriers.

Open access publication provides several benefits, including:

• Increased accessibility, as articles are freely available to readers worldwide

• Greater visibility and potential impact of published research

• Wider dissemination among researchers, clinicians, and healthcare professionals

• Support for compliance with institutional and funder open access requirements

Articles published in Clinical & Molecular Biomedicine are made available under the Creative Commons Attribution (CC BY) license, enabling broad reuse with proper attribution.

The journal may update its publication fee policy in the future. Any changes to article processing charges will be clearly communicated through the journal’s official website or policy announcements.